No Data
No Data
Stock Chart Ranking: 1st to 50th (Issue of April 18)
■What is a stock card? Fundamental Analysis score: 100 points (higher is better) Technical score: 100 points (higher is better) The Fundamental Analysis score emphasizes profit growth, while the Technical score focuses on trends. Stock code ⇒ Stock name ⇒ Market ⇒ Fundamental Analysis ⇒ Technical Top BottomTop ranking 1st to 50th< 1 2 3 4 5 6 >Rank Code Market Company name Overall judgment Fundamental Analysis score
NCS&A To Go Ex-Dividend On March 28th, 2025 With 40 JPY Dividend Per Share
March 27th (Japan Standard Time) - $NCS&A(9709.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 40 JPY dividend per share. The ex-dividend date
FFRI etc. [Interesting stocks viewed from the perspective of Volume changes]
Stock closing price change Volume * <6522> Astalisc 52,680,331,200 * <9709> NCS 89,748,126,400 * <7590> Takasho 41,726,601,700 * <3692> FFRI 30,505,001,999,700 * <4412> Science Arts 71,760,144,600 * <8150> Sanshin Electricity 20,794,319,564,00
Spot information on individual stocks (1)
IHI <7013.T> reached a high last year. Concerns about increased geopolitical risks arose after U.S. President Trump instructed a pause in the supply of Weapons to Ukraine, leading to buying in defense stocks. Mitsubishi Heavy Industries <7011.T> also rose. NCS&A <9709.T> continued to rise. The consolidated performance and Financial Estimates for the fiscal year ending in March have been raised. Ito En <2593.T> hit a low last year. The cumulative results for the third quarter of the current fiscal year (from May of last year to January of this year) showed reduced operating profit. ☆ The above article contains unverified information.
Afternoon session [Active stocks and traded stocks]
*Takasho <7590> 417 +26 Operating profit and loss was a deficit of 0.15 billion yen in the previous period, but a profit of 0.308 billion yen is expected this period. *NCS <9709> 897 +48 Performance and Financial Estimates for the fiscal year ending March 2025 have been upwardly revised. *Medikit <7749> 2591 +32 The cerebrovascular guiding assistance device 'Medilizer AGD System' is now covered by Insurance. The upper limit is heavy. *People <7865> 541 -44 Operating profit and loss was a deficit of 0.05 billion yen in the previous period and a deficit of 0.097 billion yen this period.
NCS&A surged, positively received the upward revision of profit and Financial Estimates for Dividends.
NCS & A <9709.T>, which specializes in software development, surged. It started with a buy indication and at one point, reached 909 yen, up 60 yen compared to the previous day. After the market closed on the 3rd, the earnings and Dividends Financial Estimates for the fiscal year ending March 2025 were revised upward, deemed as a reason to buy. The consolidated operating profit Financial Estimates for the full year were raised from 1.8 billion yen to 1.9 billion yen (up 16.0% year-on-year). Migration services and core solutions have been performing strongly. Furthermore, the company revised its year-end total Dividends forecast from the previous 38 yen to 40 yen (previous fiscal year performance was 30 yen).